The charges for ESRD treatment of diabetics
To evaluate the differential charges for treating end-stage renal disease (ESRD) associated with diabetes mellitus, Medicare billing data are analyzed. The charges of 244 patients in the Michigan Kidney Registry identified as having (ESRD) from diabetes are compared with charges of 902 nondiabetic p...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical epidemiology 1989, Vol.42 (2), p.111-118 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 118 |
|---|---|
| container_issue | 2 |
| container_start_page | 111 |
| container_title | Journal of clinical epidemiology |
| container_volume | 42 |
| creator | Smith, Dean G. Harlan, Linda C. Hawthorne, Victor M. |
| description | To evaluate the differential charges for treating end-stage renal disease (ESRD) associated with diabetes mellitus, Medicare billing data are analyzed. The charges of 244 patients in the Michigan Kidney Registry identified as having (ESRD) from diabetes are compared with charges of 902 nondiabetic patients. Average annual charges for ESRD treatment for diabetics are $29,671 (±27,662) which are $4695 (±1344) higher than charges for nondiabetics. The majority of the difference (84.3%) is attributable to higher inpatient hospital charges. Most of the remainder (14.5%) is attributable to higher physician and medical supply charges. Charges for treatment of diabetics are higher on all modalities of treatment, but differences are not significant among modalities. |
| doi_str_mv | 10.1016/0895-4356(89)90084-X |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78873101</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>089543568990084X</els_id><sourcerecordid>78873101</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-166deb17713059365df51c4446adb547811fdaba329256f5c8c896ed87ceae2a3</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMotVbfQGFWoshoMrlvBKn1AgVBK3QXMskZG-l0ajIVfHuntnTp6iz-G-dD6JTga4KJuMFK85xRLi6UvtQYK5ZP91CfKKlyrguyj_o7yyE6SukTYyKx5D3UK5imWNI-uprMIHMzGz8gZVUTs9Hb633WRrBtDYs2a6rMB1tCG1w6RgeVnSc42d4Ben8YTYZP-fjl8Xl4N84dw7TNiRAeSiIloZhrKrivOHGMMWF9yZlUhFTelpYWuuCi4k45pQV4JR1YKCwdoPNN7zI2XytIralDcjCf2wU0q2SkUpJ2CDoj2xhdbFKKUJllDLWNP4Zgs2Zk1gDMGoBR2vwxMtMudrbtX5U1-F1oC6XTbzc6dE9-B4gmuQALBz5EcK3xTfh_4BcobHQo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78873101</pqid></control><display><type>article</type><title>The charges for ESRD treatment of diabetics</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Smith, Dean G. ; Harlan, Linda C. ; Hawthorne, Victor M.</creator><creatorcontrib>Smith, Dean G. ; Harlan, Linda C. ; Hawthorne, Victor M.</creatorcontrib><description>To evaluate the differential charges for treating end-stage renal disease (ESRD) associated with diabetes mellitus, Medicare billing data are analyzed. The charges of 244 patients in the Michigan Kidney Registry identified as having (ESRD) from diabetes are compared with charges of 902 nondiabetic patients. Average annual charges for ESRD treatment for diabetics are $29,671 (±27,662) which are $4695 (±1344) higher than charges for nondiabetics. The majority of the difference (84.3%) is attributable to higher inpatient hospital charges. Most of the remainder (14.5%) is attributable to higher physician and medical supply charges. Charges for treatment of diabetics are higher on all modalities of treatment, but differences are not significant among modalities.</description><identifier>ISSN: 0895-4356</identifier><identifier>EISSN: 1878-5921</identifier><identifier>DOI: 10.1016/0895-4356(89)90084-X</identifier><identifier>PMID: 2493073</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Age Factors ; Charges Diabetes End-stage renal disease ; Cost-Benefit Analysis ; Costs and Cost Analysis - methods ; Diabetic Nephropathies - economics ; Diabetic Nephropathies - therapy ; Fees and Charges ; Female ; Humans ; Kidney Failure, Chronic - economics ; Kidney Failure, Chronic - therapy ; Kidney Transplantation ; Male ; Medicare - economics ; Middle Aged ; Renal Dialysis - economics ; Sex Factors ; United States</subject><ispartof>Journal of clinical epidemiology, 1989, Vol.42 (2), p.111-118</ispartof><rights>1989</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-166deb17713059365df51c4446adb547811fdaba329256f5c8c896ed87ceae2a3</citedby><cites>FETCH-LOGICAL-c403t-166deb17713059365df51c4446adb547811fdaba329256f5c8c896ed87ceae2a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/089543568990084X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,4010,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2493073$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Dean G.</creatorcontrib><creatorcontrib>Harlan, Linda C.</creatorcontrib><creatorcontrib>Hawthorne, Victor M.</creatorcontrib><title>The charges for ESRD treatment of diabetics</title><title>Journal of clinical epidemiology</title><addtitle>J Clin Epidemiol</addtitle><description>To evaluate the differential charges for treating end-stage renal disease (ESRD) associated with diabetes mellitus, Medicare billing data are analyzed. The charges of 244 patients in the Michigan Kidney Registry identified as having (ESRD) from diabetes are compared with charges of 902 nondiabetic patients. Average annual charges for ESRD treatment for diabetics are $29,671 (±27,662) which are $4695 (±1344) higher than charges for nondiabetics. The majority of the difference (84.3%) is attributable to higher inpatient hospital charges. Most of the remainder (14.5%) is attributable to higher physician and medical supply charges. Charges for treatment of diabetics are higher on all modalities of treatment, but differences are not significant among modalities.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Charges Diabetes End-stage renal disease</subject><subject>Cost-Benefit Analysis</subject><subject>Costs and Cost Analysis - methods</subject><subject>Diabetic Nephropathies - economics</subject><subject>Diabetic Nephropathies - therapy</subject><subject>Fees and Charges</subject><subject>Female</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - economics</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Kidney Transplantation</subject><subject>Male</subject><subject>Medicare - economics</subject><subject>Middle Aged</subject><subject>Renal Dialysis - economics</subject><subject>Sex Factors</subject><subject>United States</subject><issn>0895-4356</issn><issn>1878-5921</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKAzEUhoMotVbfQGFWoshoMrlvBKn1AgVBK3QXMskZG-l0ajIVfHuntnTp6iz-G-dD6JTga4KJuMFK85xRLi6UvtQYK5ZP91CfKKlyrguyj_o7yyE6SukTYyKx5D3UK5imWNI-uprMIHMzGz8gZVUTs9Hb633WRrBtDYs2a6rMB1tCG1w6RgeVnSc42d4Ben8YTYZP-fjl8Xl4N84dw7TNiRAeSiIloZhrKrivOHGMMWF9yZlUhFTelpYWuuCi4k45pQV4JR1YKCwdoPNN7zI2XytIralDcjCf2wU0q2SkUpJ2CDoj2xhdbFKKUJllDLWNP4Zgs2Zk1gDMGoBR2vwxMtMudrbtX5U1-F1oC6XTbzc6dE9-B4gmuQALBz5EcK3xTfh_4BcobHQo</recordid><startdate>1989</startdate><enddate>1989</enddate><creator>Smith, Dean G.</creator><creator>Harlan, Linda C.</creator><creator>Hawthorne, Victor M.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1989</creationdate><title>The charges for ESRD treatment of diabetics</title><author>Smith, Dean G. ; Harlan, Linda C. ; Hawthorne, Victor M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-166deb17713059365df51c4446adb547811fdaba329256f5c8c896ed87ceae2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Charges Diabetes End-stage renal disease</topic><topic>Cost-Benefit Analysis</topic><topic>Costs and Cost Analysis - methods</topic><topic>Diabetic Nephropathies - economics</topic><topic>Diabetic Nephropathies - therapy</topic><topic>Fees and Charges</topic><topic>Female</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - economics</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Kidney Transplantation</topic><topic>Male</topic><topic>Medicare - economics</topic><topic>Middle Aged</topic><topic>Renal Dialysis - economics</topic><topic>Sex Factors</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Dean G.</creatorcontrib><creatorcontrib>Harlan, Linda C.</creatorcontrib><creatorcontrib>Hawthorne, Victor M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Dean G.</au><au>Harlan, Linda C.</au><au>Hawthorne, Victor M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The charges for ESRD treatment of diabetics</atitle><jtitle>Journal of clinical epidemiology</jtitle><addtitle>J Clin Epidemiol</addtitle><date>1989</date><risdate>1989</risdate><volume>42</volume><issue>2</issue><spage>111</spage><epage>118</epage><pages>111-118</pages><issn>0895-4356</issn><eissn>1878-5921</eissn><abstract>To evaluate the differential charges for treating end-stage renal disease (ESRD) associated with diabetes mellitus, Medicare billing data are analyzed. The charges of 244 patients in the Michigan Kidney Registry identified as having (ESRD) from diabetes are compared with charges of 902 nondiabetic patients. Average annual charges for ESRD treatment for diabetics are $29,671 (±27,662) which are $4695 (±1344) higher than charges for nondiabetics. The majority of the difference (84.3%) is attributable to higher inpatient hospital charges. Most of the remainder (14.5%) is attributable to higher physician and medical supply charges. Charges for treatment of diabetics are higher on all modalities of treatment, but differences are not significant among modalities.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>2493073</pmid><doi>10.1016/0895-4356(89)90084-X</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0895-4356 |
| ispartof | Journal of clinical epidemiology, 1989, Vol.42 (2), p.111-118 |
| issn | 0895-4356 1878-5921 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78873101 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Age Factors Charges Diabetes End-stage renal disease Cost-Benefit Analysis Costs and Cost Analysis - methods Diabetic Nephropathies - economics Diabetic Nephropathies - therapy Fees and Charges Female Humans Kidney Failure, Chronic - economics Kidney Failure, Chronic - therapy Kidney Transplantation Male Medicare - economics Middle Aged Renal Dialysis - economics Sex Factors United States |
| title | The charges for ESRD treatment of diabetics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T05%3A49%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20charges%20for%20ESRD%20treatment%20of%20diabetics&rft.jtitle=Journal%20of%20clinical%20epidemiology&rft.au=Smith,%20Dean%20G.&rft.date=1989&rft.volume=42&rft.issue=2&rft.spage=111&rft.epage=118&rft.pages=111-118&rft.issn=0895-4356&rft.eissn=1878-5921&rft_id=info:doi/10.1016/0895-4356(89)90084-X&rft_dat=%3Cproquest_cross%3E78873101%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78873101&rft_id=info:pmid/2493073&rft_els_id=089543568990084X&rfr_iscdi=true |